OFFICIAL STATEMENT-Regarding Fraudulent Websites

MAGE-A1-derived peptide acetate

Description

MAGE-A1-derived peptide acetate is a short peptide sequence derived from MAGE-A1 protein. As a tumor-specific antigen, MAGE-A1-derived peptide acetate can be recognized and activated by cytotoxic T lymphocytes (CTLs), thereby generating an immune response to tumor cells expressing MAGE-A1. This immune response can lead to the lysis and death of tumor cells. MAGE-A1-derived peptide acetate can be used in the study of tumor immunity.

Product Information

Product Name MAGE-A1-derived peptide acetate
Molecular Weight 1270.51
Formula C59H103N11O19
Appearance Solid
Color White to off-white
Sequence Lys-Val-Leu-Glu-Tyr-Val-Ile-Lys-Val
Sequence Shortening KVLEYVIKV
Storage Sealed storage, away from moisture Powder -80??C 2 years -20??C 1 year *In solvent : -80??C, 6 months; -20??C, 1 month (sealed storage, away from moisture) ???? & ??Ʒ???? ???ȣ? 99.63% ѡ?????Σ? HY-P10496A-77**** Data Sheet (520 KB) SDS (252 KB) COA (287 KB)RP-HPLC (112 KB)MS (268 KB) ??Ʒʹ??ָ?? (1538 KB) ?ο????? . Ottaviani S, et al. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells. Cancer Immunology, Immunotherapy, 2005, 54: 1214-1220. ?